Predicting disease effect on the pharmacokinetics (PK) of sustained and immediate release formulations by applying physiologically based pharmacokinetic (PBPK) modelling EDCPT 2023. Poster PA-298 p.98 Eriksson J, Sjögren E, Gillon J-Y, Goyal V, Satam V, Robinson S, Caplain H, Ribeiro I, Chenel M. Pharmetheus Affiliates Senior Director, MIDD Consultant Johanna Eriksson See bio Principal Director, PBPK & PBBM Scientific Lead Erik Sjögren See bio Chief Research Officer Marylore Chenel See bio
